In pursuit of the normal progressor: the holy grail for ALS clinical trial design?

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Volume	21
Issue number	1-2
Early online date	11 Oct 2019
DOIs	https://doi.org/10.1080/21678421.2019.1675710
Publication status	Published - 2 Jan 2020

Access to Document

@article{e8de87a258bd4fabb42ea91c6eb7a4da,

title = "In pursuit of the normal progressor: the holy grail for ALS clinical trial design?",

author = "\{van Eijk\}, \{Ruben P A\} and \{van Den Berg\}, \{Leonard H\}",

year = "2020",

month = jan,

day = "2",

doi = "10.1080/21678421.2019.1675710",

language = "English",

volume = "21",

pages = "1--2",

journal = "Amyotrophic Lateral Sclerosis \& Frontotemporal Degeneration",

issn = "2167-8421",

publisher = "Taylor and Francis Ltd.",

number = "1-2",

}

TY - JOUR

T1 - In pursuit of the normal progressor

T2 - the holy grail for ALS clinical trial design?

AU - van Eijk, Ruben P A

AU - van Den Berg, Leonard H

PY - 2020/1/2

Y1 - 2020/1/2

UR - https://www.scopus.com/pages/publications/85074036029

U2 - 10.1080/21678421.2019.1675710

DO - 10.1080/21678421.2019.1675710

M3 - Editorial

C2 - 31603357

SN - 2167-8421

VL - 21

SP - 1

EP - 2

JO - Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

JF - Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

IS - 1-2

ER -